| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 08/18/2011 | WO2011100425A2 Methods and compositions for wound healing |
| 08/18/2011 | WO2011100423A1 Method and system for optimizing film production and minimizing film scrap |
| 08/18/2011 | WO2011100376A2 Methods and architecture for power optimization of iontophoretic transdermal drug delivery |
| 08/18/2011 | WO2011100295A2 Alpha-methyl-tryptophan as an inhibitor of indoleamine dioxygenase |
| 08/18/2011 | WO2011100267A1 Liquid composition comprising a non-menthol cooling agent and a thickener for treating a respiratory symptom |
| 08/18/2011 | WO2011100209A2 Magnetically sensitive drug carriers for treatment or targeted delivery |
| 08/18/2011 | WO2011099964A1 Retinol formulations and methods for their use |
| 08/18/2011 | WO2011099932A1 Smart polymers functionalized hollow silica vesicles |
| 08/18/2011 | WO2011099894A1 Agent which reduces the desire to smoke |
| 08/18/2011 | WO2011099601A1 Particulate medicinal composition |
| 08/18/2011 | WO2011099526A1 Hydrogen-containing hypotonic biocompatible solution |
| 08/18/2011 | WO2011098837A1 Method for the production of stable live vaccine formulations |
| 08/18/2011 | WO2011098799A2 Respiratory disease treatment |
| 08/18/2011 | WO2011098798A1 Process for providing a filled canister for an inhaler |
| 08/18/2011 | WO2011098578A2 Liposome system for ocular administration |
| 08/18/2011 | WO2011098552A2 Methods and compositions for the preparation of aerosols |
| 08/18/2011 | WO2011098536A1 Prasugrel in micronized, crystalline form and pharmaceutical composition thereof |
| 08/18/2011 | WO2011098518A2 Delivery of immunoglobulin variable domains and constructs thereof |
| 08/18/2011 | WO2011098499A1 Orally administrable pharmaceutical pellet of epidermal growth factor |
| 08/18/2011 | WO2011098483A1 Pharmaceutical compositions comprising a combination of metformin and sitagliptin |
| 08/18/2011 | WO2011098444A1 Active substance-releasing wound dressing |
| 08/18/2011 | WO2011098391A1 A dermatological composition comprising a combination of adapalene and benzoyl peroxide for the treatment of acne in non- caucasian population with decrease of post- inflammatory hyperpigmentation |
| 08/18/2011 | WO2011098285A2 Dermatological, pharmaceutical composition suitable for oligonucleotides |
| 08/18/2011 | WO2011098194A2 Pharmaceutical mini-tablets for sustained release of flecainide acetate |
| 08/18/2011 | WO2011097857A1 Antihypertensive pharmaceutical composition |
| 08/18/2011 | WO2011097788A1 Use of pentoxifylline for preventing or treating constipation |
| 08/18/2011 | WO2011079317A3 Ultrasound-activated nanoparticles as imaging agents and drug delivery vehicles |
| 08/18/2011 | WO2011079234A3 Highly permeating terbinafine formulation for treating onychomycosis |
| 08/18/2011 | WO2011077402A3 Amphiphilic polymer functionalised by methionine |
| 08/18/2011 | WO2011077347A3 Active ingredient delivery system |
| 08/18/2011 | WO2011076749A3 Solid pharmaceutical dosage form of ticagrelor |
| 08/18/2011 | WO2011050039A3 Modular functional peptides for the intracellular delivery of nanoparticles |
| 08/18/2011 | WO2011049960A9 Compositions and methods for the treatment of sinonasal disorders |
| 08/18/2011 | WO2011047277A3 Release of agents from cells |
| 08/18/2011 | WO2011047227A3 Water soluble drug-solubilizer powders and their uses |
| 08/18/2011 | WO2011046832A3 Granulysin in immunotherapy |
| 08/18/2011 | WO2011046609A3 Encapsulation |
| 08/18/2011 | WO2011044175A3 Patch and patch assembly for iontophoretic transdermal delivery of active agents for therapeutic and medicinal purposes |
| 08/18/2011 | WO2011041680A3 Compositions and methods of prophylaxis for contact dermatitis |
| 08/18/2011 | WO2011011318A8 Process for the continuous manufacture of a polyisobutylene based transdermal patch |
| 08/18/2011 | WO2010144865A9 Methods for treating gastrointestinal disorders |
| 08/18/2011 | WO2010124198A3 Agglomerate formulations useful in dry powder inhalers |
| 08/18/2011 | WO2010100657A3 Oral controlled release dosage forms for water soluble drugs |
| 08/18/2011 | WO2010084041A3 Pharmaceutical compositions comprising a hcv polymerase inhibitor prodrug |
| 08/18/2011 | US20110202041 Fastening means for implantable medical control assembly |
| 08/18/2011 | US20110201654 Therapeutic combination |
| 08/18/2011 | US20110201645 Method Of Treating Attention Deficit Disorders With D-Threo Methylphenidate |
| 08/18/2011 | US20110201586 Pharmaceutical composition and method for treating hypogonadism |
| 08/18/2011 | US20110201115 Method and apparatus for production of a skin graft and the graft produced thereby |
| 08/18/2011 | US20110200695 Gel composition for filling a breast milk duct prior to surgical excision of the duct or other breast tissue |
| 08/18/2011 | US20110200681 Abuse Resistant Drug Formulation |
| 08/18/2011 | US20110200680 Water insoluble polymer: starch-based film coatings for colon targeting |
| 08/18/2011 | US20110200679 Method for manufacturing sustained release microsphere by solvent flow evaporation method |
| 08/18/2011 | US20110200678 Manufacturing method and apparatus of ultrafine particles having uniform particle size distribution |
| 08/18/2011 | US20110200677 Prostate specific membrane antigen (psma) targeted nanoparticles for therapy of prostate cancer |
| 08/18/2011 | US20110200676 Cross-linked oxidated hyaluronic acid for use as a vitreous substitute |
| 08/18/2011 | US20110200675 Drug delivery vehicles, methods of manufacture, and methods of use thereof |
| 08/18/2011 | US20110200674 Antimicrobial foam and method of manufacture |
| 08/18/2011 | US20110200673 Oxidized heparin fractions and their use in inhibiting angiogenesis |
| 08/18/2011 | US20110200672 Coated tablet formulation and method |
| 08/18/2011 | US20110200671 Method of treating a disease condition susceptible to baclofen therapy |
| 08/18/2011 | US20110200670 Nicotine Containing Soft Gelatin Pastilles |
| 08/18/2011 | US20110200669 Method and compositions of civamide to treat disease of the intestines |
| 08/18/2011 | US20110200668 Pharmaceutical composition for preventing dysbiosis associated with enteral administration of antibiotics |
| 08/18/2011 | US20110200667 Veterinary pharmaceutical formulacion that comprises an rna recombinant particle that encodes for a cu/zn superoxide dismutase protein of ruminant pathogenic bacteria and at least one rna alphavirus belonging to the semliki forest virus family |
| 08/18/2011 | US20110200666 UV PROTECTION AGENT FOR THE SKIN OR HAIR HAVING A UV FILTER SUBSTANCE ENCAPSULATED IN A VESICULAR CARRIER SYSTEMü |
| 08/18/2011 | US20110200665 Novel Thermosensitive Liposomes Containing Therapeutic Agents |
| 08/18/2011 | US20110200663 Methylphenidate patch preparation |
| 08/18/2011 | US20110200662 Method For The Treatment Of Proliferative Disorders Of The Eye |
| 08/18/2011 | US20110200661 Acrylic hydrogels with pendant cyclodextrins, preparation method thereof and use of same as release systems and contact lens components |
| 08/18/2011 | US20110200660 Poly(ester amide)-based drug delivery systems with controlled release rate and morphology |
| 08/18/2011 | US20110200659 System and method for loading a beneficial agent into a medical device |
| 08/18/2011 | US20110200657 Methods of using nanoemulsion compositions having anti-inflammatory activity |
| 08/18/2011 | US20110200654 Microcapsules having an envelope composed essentially of silsesquioxane homopolymers or copolymers |
| 08/18/2011 | US20110200647 Pulmonary disease treatment |
| 08/18/2011 | US20110200646 The TRPVL Antagonists SB-795498 For Treating Rhinitis |
| 08/18/2011 | US20110200645 DHA Free Fatty Acid Emulsions |
| 08/18/2011 | US20110200644 DHA Ester Emulsions |
| 08/18/2011 | US20110200643 Emulsions for producing medicinal products |
| 08/18/2011 | US20110200642 Compositions and Methods to Promote Implantation and Engrafment of Stem Cells |
| 08/18/2011 | US20110200539 Sprayable composition comprising extract of red vine leaves |
| 08/18/2011 | US20110200538 Alternan Derivatives |
| 08/18/2011 | US20110200537 Laser marked dosage forms |
| 08/18/2011 | US20110200530 Targeting construct comprising anti-polymer antibody and contrast/therapeutic agents binding to the same |
| 08/18/2011 | US20110200528 Cyclized ngr peptide compounds, compositions, and methods of their use |
| 08/18/2011 | US20110200527 Peptide Ligand Directed Drug Delivery |
| 08/18/2011 | US20110200525 Vhh antibody fragments for use in the detection and treatment of cancer |
| 08/18/2011 | DE102004045186B4 Liposomen, die die intrazelluläre Penetration von Wirkstofen stimulieren, deren Verwendung zur Herstellung von topischen pharmazeutischen bzw. kosmetischen Zusammensetzungen, die diese Liposomen enthalten sowie ein Screening-Verfahren zum Auffinden von Substanzen zur Stimulierung der intrazellulären Penetration Liposomes, which stimulate the intracellular penetration of Wirkstofen, their use for the preparation of topical pharmaceutical and cosmetic compositions containing these liposomes as well as a screening method for finding substances for stimulating the intracellular penetration |
| 08/18/2011 | CA2827049A1 Dermatological pharmaceutical composition suitable for oligonucleotides |
| 08/18/2011 | CA2789536A1 Method and system for optimizing film production and minimizing film scrap |
| 08/18/2011 | CA2789335A1 Methods of normalizing measured drug concentrations and testing for non-compliance with a drug treatment regimen |
| 08/18/2011 | CA2789276A1 New signaling molecule involved in ultraviolet damage to skin |
| 08/18/2011 | CA2789055A1 Orally administrable pharmaceutical pellet of epidermal growth factor |
| 08/18/2011 | CA2788834A1 Liquid composition comprising a non-menthol cooling agent and a thickener for treating a respiratory symptom |
| 08/18/2011 | CA2788284A1 Alpha-methyl-tryptophan as an inhibitor of indoleamine dioxygenase |
| 08/18/2011 | CA2788015A1 Process for providing a filled canister for an inhaler |
| 08/18/2011 | CA2787718A1 Methods and compositions for the preparation of aerosols |
| 08/18/2011 | CA2786911A1 Cross-linked oxidated hyaluronic acid for use as a vitreous substitute |
| 08/18/2011 | CA2785858A1 Particulate pharmaceutical composition |
| 08/17/2011 | EP2356995A2 Process of preparation of formulations of the peptide Angiotensin-(1-7) and its analogues, agonists and antagonists using cyclodextrins, liposomes and biodegradable polymers and/or mixtures and products thereof |